Free tool
LHCIX and IXJ: how much do they overlap?
Enter any two ETFs or mutual funds to see how much of their portfolios overlap, using each fund's latest SEC holdings report.
Bottom line
Overlap between LHCIX and IXJ
47% of their top holdings overlap by weight, with 9 securities in common among each fund's top 25. They share a meaningful core but differ in the rest of the portfolio. Note that IXJ holds far more positions (124 vs 61), so it is broader beyond the top names.
| Holding | % of LHCIX | % of IXJ |
|---|---|---|
| Eli Lilly & Co | 10.40% | 10.93% |
| UnitedHealth Group Inc | 5.39% | 4.40% |
| Johnson & Johnson | 4.96% | 7.04% |
| Novartis AG | 4.19% | 3.71% |
| Gilead Sciences Inc | 3.53% | 2.04% |
| CVS Health Corp | 3.33% | 1.71% |
| Thermo Fisher Scientific Inc | 2.31% | 2.42% |
| Vertex Pharmaceuticals Inc | 2.24% | 1.64% |
| AstraZeneca PLC | 1.97% | 3.76% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Popular overlap checks
| Pair | Overlap | |
|---|---|---|
| VOO vs VTI | 99% | Details |
| QQQ vs VGT | 57% | Details |
| SCHD vs VYM | 24% | Details |
| VOO vs QQQ | 68% | Details |
| VTI vs VXUS | 0% | Details |
| VUG vs QQQ | 69% | Details |
| JEPI vs SCHD | 2% | Details |
Source: SEC Form N-PORT; top-25 holdings, weight-normalized